Paracrine Molecules of Mesenchymal Stem Cells for Hematopoietic Stem Cell Niche
Open Access
- 22 September 2011
- journal article
- review article
- Published by Hindawi Limited in Bone Marrow Research
- Vol. 2011, 1-8
- https://doi.org/10.1155/2011/353878
Abstract
Hematopoietic stem cells (HSCs) and mesenchymal stem cells (MSCs) are both adult stem cells residing in the bone marrow. MSCs interact with HSCs, they stimulate and enhance the proliferation of HSCs by secreting regulatory molecules and cytokines, providing a specialized microenvironment for controlling the process of hematopoiesis. In this paper we discuss how MSCs contribute to HSC niche, maintain the stemness and proliferation of HSCs, and support HSC transplantation.Keywords
Funding Information
- National Natural Science Foundation of China (30871273, 30971496, U1032003)
This publication has 103 references indexed in Scilit:
- Bone Marrow Stem Cells in Clinical Application: Harnessing Paracrine Roles and Niche MechanismsPublished by Springer Science and Business Media LLC ,2010
- Mesenchymal and haematopoietic stem cells form a unique bone marrow nicheNature, 2010
- The effect of incorporation of SDF-1α into PLGA scaffolds on stem cell recruitment and the inflammatory responseBiomaterials, 2010
- Mesenchymal stem cells in hematopoietic stem cell transplantationCytotherapy, 2009
- Adult stem cells and their trans-differentiation potential—perspectives and therapeutic applicationsJournal of Molecular Medicine, 2008
- IFN‐γ activation of mesenchymal stem cells for treatment and prevention of graft versus host diseaseEuropean Journal of Immunology, 2008
- Wnt Signaling in the Niche Enforces Hematopoietic Stem Cell Quiescence and Is Necessary to Preserve Self-Renewal In VivoCell Stem Cell, 2008
- Hematopoiesis: An Evolving Paradigm for Stem Cell BiologyCell, 2008
- A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor developmentThe Journal of Experimental Medicine, 2006
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006